Massimo Bernardi
Overview
Explore the profile of Massimo Bernardi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
2662
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marconi G, Petracci E, Lanzarone G, Vetro C, Martelli M, Papayannidis C, et al.
Am J Hematol
. 2025 Jan;
100(4):708-711.
PMID: 39831709
Expectation of survival of patients receiving HMA + VEN is influenced by pre-treatment comorbidity burden.
2.
Cairoli R, Gatti A, Grillo G, Stefanucci M, Di Camillo B, Fumagalli M, et al.
Am J Hematol
. 2024 Dec;
100(2):346-349.
PMID: 39659145
Samples from 34 adult patients newly diagnosed with core binding factor leukemia (CBFL) were collected both at the time of diagnosis and at relapse and were centrally analyzed. Eligible patients...
3.
Russo D, Polverelli N, Bernardi S, Santarone S, Farina M, Borlenghi E, et al.
Lancet Haematol
. 2024 Sep;
11(11):e830-e838.
PMID: 39312920
Background: Access to allogeneic haematopoietic stem-cell transplantation (HSCT) remains challenging for older patients (aged >60 years) with acute myeloid leukaemia. We aimed to evaluate the efficacy of venetoclax plus decitabine...
4.
Diral E, Furnari G, Bruno A, Greco R, Clerici D, Marktel S, et al.
Front Oncol
. 2024 Jul;
14:1391743.
PMID: 38978738
Despite allogeneic hematopoietic stem cell transplant (allo-HCT) and the development of novel FLT3 inhibitors in both induction (midostaurin) and in the relapsed/refractory setting (gilteritinib), FLT3-ITD mutated leukemia (FLT3-ITD+ AML) still...
5.
Diral E, Catalano G, Cicinelli M, Distefano A, Mastaglio S, Vago L, et al.
Front Oncol
. 2024 May;
14:1399894.
PMID: 38756666
Chronic myelomonocytic leukemia (CMML) is a rare hematological disorder characterized by variable risk of evolution to acute myeloid leukemia; to date, allogeneic stem cell transplantation is the only curative treatment....
6.
Diral E, Campochiaro C, Tomelleri A, Bergonzi G, Pizzano U, Ponzoni M, et al.
Front Immunol
. 2024 Feb;
15:1354130.
PMID: 38333211
VEXAS syndrome is an acquired autoinflammatory disease characterized in most cases by cytopenias and macrocytic anemia. Dyshematopoiesis is a frequent finding in chronic inflammatory conditions and therefore, cytopenias are not...
7.
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies
Mori G, Diotallevi S, Farina F, Lolatto R, Galli L, Chiurlo M, et al.
Microorganisms
. 2024 Jan;
12(1).
PMID: 38257945
Invasive fungal diseases (IFDs) still represent a relevant cause of mortality in patients affected by hematological malignancies, especially acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS) undergoing remission induction chemotherapy,...
8.
Rossi G, Borlenghi E, Zappasodi P, Lussana F, Bernardi M, Basilico C, et al.
Cancers (Basel)
. 2024 Jan;
16(2).
PMID: 38254875
A retrospective survey was conducted in hematologic centres of the Rete Ematologica Lombarda (REL) on 529 older AML patients seen between 2020-2022. Compared to 2008-2016, the use of intensive chemotherapy...
9.
Gurnari C, Pascale M, Vitale A, Diral E, Tomelleri A, Galossi E, et al.
Am J Hematol
. 2023 Dec;
99(2):254-262.
PMID: 38108611
VEXAS is a prototypic hemato-inflammatory disease combining rheumatologic and hematologic disorders in a molecularly defined nosological entity. In this nationwide study, we aimed at screenshotting the current diagnostic capabilities and...
10.
Giglio F, Xue E, Barone A, Lorentino F, Greco R, Ruggeri A, et al.
Transplant Cell Ther
. 2023 May;
29(8):519.e1-519.e9.
PMID: 37244644
Several strategies have been explored with the attempt of improving the safety and feasibility of umbilical cord blood transplantation (UCBT) in adults. The aim of this retrospective analysis was to...